NT5E and glioma: Because expression of CD73 on tumor cells, independent of its expression on immune cells, has previously been described as required for an antitumor immune response to A2aR inhibition and genetic knockout (14), we evaluated the expression of CD73 on the murine glioma cell line GL261.